Synergy CHC Corp (SNYR): Narx/daromad koeffitsiyenti

Synergy CHC Corp (SNYR) brendining ramzi va logotipi

Geopolitik beqarorlik xomashyo logistikasini buzmoqda va Amerika xarid qilish qobiliyatini pasaytirmoqda, bu esa Synergy CHC Corp (SNYR) daromadliligiga bosim o'tkazmoqda. GURU.Markets platformasidagi taxminiy P/S ko'rsatkichi onlayn segmentdagi kuchli bosim va iste'mol siklidagi turg'unlik tufayli kritik nuqtaga yetgan. Biroq, D2C kanallarining samaradorligi va IT infratuzilmasi ushbu xavflarni yumshatadi. 0.00 qiymati ushbu metrikaning darajasini ko'rsatadi.

SNYR Synergy CHC Corporation Narxning daromadga nisbati (02.04.2025 - 03.10.2026)

Synergy CHC Corp. (SNYR) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:Synergy CHC Corp
Synergy CHC seriyali mahsuloti

Synergy CHC Corp (SNYR) kompaniyasining autsorsing modeli ishlab chiqarish risklarini tashqi pudratchilarga o'tkazadi, bu esa tushumni boshqaruv samaradorligining asosiy ko'rsatkichi qiladi. Fundamental P/S koeffitsiyenti biznesning bozor qiymatini uning yillik aylanmasiga nisbatan aks ettiradi va sotuvlar birligi uchun xarajatlarni baholash imkonini beradi. Ushbu metrika bozor kapitalizatsiyasining kompaniyaning umumiy tushumiga nisbati sifatida hisoblanadi. Ushbu grafikdagi haddan tashqari past qiymatlar "qiymat tuzog'i" va uzoq muddatli kapital stagnatsiyasi xavfi haqida signal berishi mumkin.

Synergy CHC Corp kimlar bilan raqobatlashadi

HLN (Haleon) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Kenvue Inc KVUE|Verona Pharma Corp - Narxning daromadga nisbati|MENS: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Ligand Pharmaceuticals LGND|Amneal Pharmaceuticals Inc (AMRX) - Narxning daromadga nisbati|Perrigo Company PLC - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati alvotech.com|P/S multiplikatori Liquidia Technologies|Narxning daromadga nisbati Galapagos Genomics (GLPG)|ANIP: Narxning sotuvga nisbati|P/S multiplikatori MNKD (MannKind Corp)|Narx/daromad koeffitsiyenti Amphastar (AMPH)|PCRX: Kapitalizatsiyaning daromadga nisbati|SPRY - P/S multiplikatori|Theravance Biopharma, Inc. (TBPH) - Narxning daromadga nisbati|AQST (Aquestive Therapeutics) - Narxning daromadga nisbati|SCPH (scpharmaceuticals.com) - P/S multiplikatori|TECX: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EPRX (Eupraxia Pharmaceuticals)|Bozor kapitallashuvining daromadga nisbati BHST|Invizyne Technologies - P/S multiplikatori|oramed.com (ORMP) - Kapitalizatsiyaning daromadga nisbati|ENTX (enterabio.com) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiya va daromad nisbati HYFT|ABVC (ABVC BioPharma, Inc) - P/S multiplikatori|P/S multiplikatori cumberlandpharma.com|Narxning daromadga nisbati Quantum BioPharma (QNTM)|FibroGen (FGEN) - Narx/daromad multiplikatori|P/S multiplikatori TELO (telomirpharma.com)|RANI - Kapitalizatsiyaning daromadga nisbati|RLYB: Kapitalizatsiyaning daromadga nisbati|lexariabioscience.com (LEXX) - Kapitalizatsiyaning daromadga nisbati|Pulmatrix Inc (PULM) - Narxning daromadga nisbati|PTHL: Kapitalizatsiyaning sotish hajmiga nisbati|APM (Aptorum Group Ltd) - P/S multiplikatori|Lyra Therapeutics Inc (LYRA) - Narx/daromad koeffitsiyenti|P/S multiplikatori IBO|Kapitalizatsiyaning sotish hajmiga nisbati TNFA|cbdMD, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PRFX|Altamira Therapeutics Ltd. - P/S multiplikatori|LIPO: Narxning daromadga nisbati|OPTN: P/S multiplikatori|Narxning sotuvga nisbati PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - P/S multiplikatori|PTPI (Petros Pharmaceuticals Inc) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori QLI|SLRN - Sotuvga nisbatan narx|P/S multiplikatori TFFP (TFF Pharmaceuticals, Inc)